0001213900-23-075010.txt : 20230907
0001213900-23-075010.hdr.sgml : 20230907
20230907163210
ACCESSION NUMBER: 0001213900-23-075010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20230907
DATE AS OF CHANGE: 20230907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryan John L
CENTRAL INDEX KEY: 0001679825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 231242674
MAIL ADDRESS:
STREET 1: C/O KADMON HOLDINGS, LLC
STREET 2: 450 E. 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-05
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001679825
Ryan John L
C/O UNICYCIVE THERAPEUTICS, INC.
4300 EL CAMINO REAL SUITE 210
LOS ALTOS
CA
94022
1
0
0
0
0
Stock Options
0.76
2023-09-05
4
A
0
112147
0
A
2033-09-05
Common Stock
112147
123775
D
37,382 options vest on June 26, 2024, 37,382 options vest on June 26, 2025 and 37,383 vest on June 26, 2026.
/s/ John Ryan
2023-09-07